Article
The clinical impact of pharmacogenetics on the treatment of epilepsy.
Epilepsia - 1 Jan 2009
Löscher Wolfgang, Klotz Ulrich, Zimprich Fritz, Schmidt Dieter
Abstract excerpt
Drug treatment of epilepsy is characterized by unpredictability of efficacy, adverse drug reactions, and optimal doses in individual patients, which, at least in part, is a consequence of genetic variation. Since genetic variability in drug metabolism was reported to affect the treatment with phenytoin more than 25 years ago, the ultimate goal of pharmacogenetics is to use the genetic makeup of an individual to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
